Fundraising Fox

Mucolife

1 known investors

MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.

Founders & leadership

TPThaher Pelaseyed
Thaher PelaseyedinCo-founder & Chief Executive Officer
GCGunnar C. Hansson
Gunnar C. HanssoninCo-founder & Chief Scientific Officer
KJKicki Johansson
Kicki JohanssoninChief Development Officer
MKMaarten Kraan
Maarten KraaninChief Clinical Officer
JSJim Shaffer
Jim ShafferinChief Business Officer

Investors · 1

Frequently asked questions

What does Mucolife do?
MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.
Who founded Mucolife?
Mucolife was founded by Thaher Pelaseyed, Gunnar C. Hansson.
Who are Mucolife's investors?
Mucolife's investors include Health Wildcatters.